Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation

Project description

EU-Africa collaboration in fostering infectious disease drug discovery

Infectious diseases disproportionately burden Sub-Saharan Africa, which lacks a critical mass of appropriately skilled scientists, access to general infrastructure, enabling technology platforms, and expertise for drug discovery research. The EU-funded RAFIKI project will therefore strengthen early drug discovery capacity in Africa, focusing on infectious diseases like malaria and tuberculosis. It will establish training hubs in South, East, and West Africa to support early- and mid-career researchers through training visits, mentorships, workshops and online courses. The project will also facilitate knowledge sharing for compound library curation and improve data management using the collaborative drug discovery (CDD) vault. The consortium will engage with industry stakeholders and potential public and private funders to secure funding.

Objective

The RAFIKI consortium will support capacity building for early drug discovery in Africa with a focus on infectious diseases (e.g. malaria, tuberculosis). Sub-Saharan Africa is disproportionately burdened by such diseases yet lacks a critical mass of appropriately skilled scientists and access to general infrastructure, enabling technology platforms and expertise for drug discovery research. RAFIKI will leverage existing collaborations within the consortium to build the knowledge and technical capacities of research institutions across Africa. RAFIKI will establish regional training hubs in South, East and West Africa to support local capacity/skillset building for early-/mid-career researchers via bidirectional scientific training visits, mentorships, regional in-person workshops and online training courses. To establish the requisite infrastructure for future drug discovery R&I, knowledge and procedures will be shared for compound library curation at partner institutions (i.e. workflows, open database creation, library sharing capabilities), and data management capacities will be bolstered using the Collaborative Drug Discovery (CDD) Vault. To secure funding beyond the project lifetime, the consortium will liaise with relevant industrial actors and potential public/private funders.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-INFRA-2024-DEV-01

See all projects funded under this call

Coordinator

EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC)
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 303 000,00
Address
ROBERT-ROSSLE-STR. 10
13125 Berlin
Germany

See on map

Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (7)

Partners (1)

My booklet 0 0